Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SimCorp A/S – Share buyback program

Company Announcement no. 20/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning

RaySearch Laboratories AB (publ) is proud to announce an agreement to collaborate with GE Healthcare, a leading global medical technology, diagnostics, and digital solutions company, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to make use of the latest advancements in treatment planning technology.The companies aim to combine RaySearch’s advanced treatment planning system RayStation®* with GE Healthcare’s leading multi-modality (CT/MR/molecular imaging) simulator systems to make cancer treatment faster and more precise.  More than 60

Plane and bus companies across Europe urged to allow pet-friendly passage for Ukrainian refugees

Humane Society International/Europe warns of pets being abandoned because some travel companies refuse their transportBRUSSELS (May 9, 2022) — Travel companies are urged by Humane Society International/Europe to provide safe, pet-friendly passage for Ukrainian refugees travelling with their animals, to avoid cats, dogs and others being abandoned at bus or airplane terminals due to being refused travel. The animal protection charity’s teams in Poland and Romania were alerted that refugees attempting to travel further into the EU are faced with the impossible decision to leave their pets

poLight ASA - Invitation to presentation of Q1 2022 results

poLight ASA will release its first quarter 2022 results on Thursday 12 May 2022 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com  and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST through live webcast. Please join the Q1 2022 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20220512_6/ 

Ingka Group to accelerate expansion by investing EUR 3 billion by end of next year

Ingka Group, the largest IKEA retailer, will accelerate expansion by investing more than EUR 3 billion in new and existing stores by the end of next year to become more accessible for customers – whenever and wherever they want to interact with IKEA.Life at home has never been more important and the new investment reflects the ongoing retail transformation and the company’s unchanged determination to get closer to where customers are, while navigating global disruptions caused by the war in Ukraine and the pandemic. As online shopping continues to increase rapidly, physical IKEA stores

Read original

Viaplay adds ‘R.S.V.P.’ to Swedish original film slate

· Lisa Carlehed (‘The Emigrants’) stars in Swedish romantic comedy film   · ‘R.S.V.P.’ is Viaplay’s latest feature-length Nordic production · Viaplay set to premiere at least 70 Originals in 2022 The Swedish romantic comedy ‘R.S.V.P.’ will be the next original film in Viaplay’s ongoing investment in feature-length Nordic storytelling. Set to premiere in the fourth quarter of 2022, ‘R.S.V.P.’ brings together some of Sweden’s hottest talents in front of and behind the camera, with the lead role played by Lisa Carlehed, recently nominated for Best Actress at Sweden’s 2022 Guldbagge

Relais Group Plc will publish its Interim Management Statement from January-March 2022 on 12 May 2022 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release, 9 May 2022 at 10:00 a.m. EET Relais Group Plc will publish its Interim Management Statement from January-March 2022 on Thursday, 12 May 2022 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on 12 May 2022, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Pekka Raatikainen will host the event. The webcast can be followed at https://relais.videosync.fi/interimreport-q1-

Valmet signs an agreement with Sponda Ltd on the renting of a new office building to be designed and constructed in Tikkurila, Vantaa

Valmet Oyj’s press release on May 9, 2022 at 10:00 a.m. EESTValmet has signed an agreement with the property investment company Sponda Ltd on the renting of a new office building that will be designed and constructed in Tikkurila, Vantaa in Finland. The office building will be located in the immediate vicinity of the Tikkurila station at the address Lauri Korpisen katu 9. Valmet’s rented floor area in the building will be approximately 13,000 floor square meters. Construction of the development project is scheduled to start this year, and the work is estimated to be completed by the end of

Mourning the loss of Curt Bergfors

It is with great sadness we share that Curt Bergfors, founder of MAX, principal owner and working Chairman of the Board, has passed away on May 8, 2022. He leaves behind his wife, four children, grandchildren, as well as relatives and friends. Curt was a visionary with a wealth of ideas and knowledge, something that has characterized MAX’s development and growth throughout the entire history of the company. His commitment to societal issues and sustainability has also had great impact far beyond the company and the country of Sweden.  - Curt was a beloved husband, father,

Aqilion strengthens its pipeline with a drug candidate in chronic inflammatory bowel diseases, IBD

Aqilion has nominated Girtab, a program from the company’s research activities, for further preclinical and clinical development. The goal of Girtab is to develop a new treatment for chronic inflammatory bowel diseases. Girtab complements Aqilion’s pipeline well and strengthens the company’s strategic focus on drug targets and programs with great potential in inflammatory diseases. The development of Girtab has come so far that there is now a clinical drug candidate, AQ312, to be tested in safety studies in a preclinical development program. In parallel, the development of a dosage form

K-Fastigheter obtains building rights for 130 rental apartments in Höganäs

K-Fastigheter has entered into an agreement with SBB on the acquisition of the subsidiary that owns part of properties Olympia 14 and Stataren 2 in Höganäs. K-Fastigheter plans to build approximately 130 rental apartments in the Group’s proprietary concept buildings Apartment Block and Lateral Low-Rise in Höganäs.K-Fast Holding AB (“K-Fastigheter”) acquires parts of two properties in Höganäs and divests properties in Kristianstad and Hässleholm through a joint venture transaction with SBB. The transaction involves K-Fastigheter acquiring companies owning part of Olympia 14 and part of

Realheart is recruiting Lead Systems Engineer

Press release, 9 May 2022 Realheart has recruited a Lead Systems Engineer from Texas. Bruce Wedding most recently came from a role as a senior software engineer at LivaNova, PLC. Bruce will start working for Realheart on May 9, at the same time as he plans to move himself and his family to the head office in Västerås.Now Realheart strengthens the product development team with Bruce Wedding, who has over 30 years of diverse software engineering and project management experience. In his current role, he is the team leader in the development of a Class III implantable medical device. Bruce

Coor’s climate goals approved by Science Based Targets

Coor’s climate goals have been validated by the Science Based Targets Initiative (SBTi).  In order to limit global warming to 1.5°C, Coor has set a target of reducing its emissions of greenhouse gases under scope 1 and scope 2 by 75% by 2030. To address scope 3, Coor has set a target to ensure that 75% of the company’s scope 3 emissions come from suppliers with targets approved by SBTi.Coor’s overall goal is to develop the business in the best way and maximize financial returns while at the same time helping to build a better future for humans and the environment.   “The fact that our

AcouSort selected by EIC for participation in leading medical exhibition

AcouSort has been selected by the European Innovation Council (EIC) for participation in the European Pavilion at BIO2022 after a highly competitive evaluation process. AcouSort is thus one of 20 European companies selected by EU for full sponsorship at America’s leading medical exhibition, taking place in San Diego June 13-16.– It is of course incredibly inspiring to be one of the 20 European SMEs or startups selected by EIC for participation at BIO2022. We see this as one of the most important conferences in the healthcare and biotech industry, where most leading companies are represented,

DSRT: Desert Control appoints Head of Group Marketing and Communications

ISSUER DESERT CONTROL AS Sandnes, Norway, 09 May 2022Norwegian AgTech company Desert Control has developed a liquid natural clay(LNC) that restores soil and reduces water usage for agriculture and greenlandscapes. The company is now entering the commercial stage in the Middle Eastand is further launching validation initiatives and pilots in the United States.Desert Control strengthens its leadership team with a Head of Group Marketingand Communications to accelerate commercialization, develop its outreachstrategy and elevate global awareness.Desert Control appoints

Cereno Scientific to present candidate drug CS585 preclinical data at EHA 2022 – the premier medical congress for hematology

Cereno Scientific (XSAT: CRNO B) today announced that an abstract on preclinical drug candidate CS585 has been accepted as an oral presentation by the Scientific Program Committee at the European Hematology Association (EHA) 2022 Hybrid Congress in Vienna, Austria, on June 9-12, 2022. The abstract: “CS585 is a first-in-class compound targeting the IP receptor for prevention of thrombosis without increased risk of bleeding” will be presented by Dr. Michael Holinstat, lead of Cereno’s preclinical development programs at University of Michigan and Director of Translational Research at Cereno.“

Invitation to Noreco First Quarter 2022 Earnings Call

Oslo, 9 May 2022: Norwegian Energy Company ASA ("Noreco" or "the Company") will publish its financial results for the first quarter of 2022 on Tuesday 10 May 2022 at 07:00 (CEST).   An earnings call, available as a webcast, will be hosted at 11:00 (CEST). To join webcast:  https://channel.r oyalcast.com/landingpage/hegnarmedia/20220510_10/  ***  Contact: Cathrine Torgersen, EVP Investor Relations & ESG Email: ct@noreco.com Phone: +47

Caverion Corporation’s financial reporting and Annual General Meeting in 2023

Caverion Corporation Stock exchange release 9 May 2022 at 9.20 a.m. EESTCaverion Corporation’s financial reporting and Annual General Meeting in 2023 Caverion will publish its Financial Statements Release for 2022 on Thursday 9 February 2023 at approximately 8:00 a.m. Finnish time (EET). Annual Review 2022 including the financial statements will be published during week 9/2023, at the latest. In addition, Caverion will publish three financial reports in 2023: Interim report for January−March on 27 April 2023Half yearly report for January−June on 3 August 2023Interim report for

Changes in Caverion’s Group Management Board: Mikko Kettunen appointed as CFO

Caverion Corporation Stock exchange release 9 May 2022 at 9.10 a.m. EESTChanges in Caverion’s Group Management Board: Mikko Kettunen appointed as CFO Mikko Kettunen (45), M.Sc. (Econ.), has been appointed as CFO of Caverion Group and a member of the Group Management Board of Caverion Corporation as of 8 November 2022 at the latest. He will report to Jacob Götzsche, President and CEO. Mikko Kettunen’s latest position has been the CFO of the Finnish stock-listed composite solutions manufacturer Exel Composites Plc, where he has also acted earlier in a combined role as CFO and Business

Ted Fjällman new board member at XNK Therapeutics

XNK Therapeutics AB (“XNK”) today announced that Ted Fjällman, Partner at Flerie Invest, has joined the company’s board of directors.Ted Fjällman is Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 25 companies in the US, UK, Sweden, the Netherlands and other countries. Ted has been CEO and board member of several biotech companies engaged in a wide range of areas including immunology, oncology and biologics development and manufacturing. He holds a Ph.D. in Biotechnology and Immunology from the University of Guelph, Canada, and splits his

Akobo Minerals reaches fundamental milestone on the way to gold production

Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has reached an agreement with the South African company Solo Resources (Pty) Ltd for delivery of a processing plant for production of gold at the Segele Mine.· Commissioning expected to start by end of first quarter 2023 · The plant will be tailored to process the highly gold rich Segele Mine ore with an Inferred and Indicated Mineral Resource Estimate of 69 kOz gold @22.7 grams per tonne · The plant is designed to process 10 tons of mass per

Krister Zackari appointed Managing Director of Fazer Lifestyle Foods

Krister Zackari has been appointed Managing Director of Fazer Lifestyle Foods and member of the Fazer Leadership Team. Krister joins Fazer from Norrmejerier – Sweden’s 3rd largest dairy company – where he has held the position of CEO since 2021. He will assume his new position at Fazer on 1 July 2022.Krister Zackari has a strong background from various FMCG companies and geographies with more than 25 years’ experience in international business. Prior to his current position, he has held several senior executive and leadership positions, such as Managing Director of Kraft Foods / Mondelēz

Mol Cancer Ther Publishes Bexmarilimab Research

Faron Pharmaceuticals Ltd. (“Faron” or “Company”)   Molecular Cancer Therapeutics Publishes Research on the Nonclinical Characterization of Bexmarilimab   Press release, May 9, 2022 at 02:00 AM (EDT) / 07:00 AM (BST) / 09:00 AM (EEST)   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the American Association for Cancer Research (AACR)

SBB sells building rights and acquires community service properties

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) sells building rights for residential properties in Höganäs to K-Fast Holding AB (publ) (“K-Fastigheter”) for a total of approximately SEK 50 million. The building rights are created within SBB's existing residential properties. Closing will take place when  the zooning plan becomes legally binding. SBB also acquires two preschools in Kristianstad and an LSS property (a home for persons with certain functional impairments) in Hässleholm from K-Fastigheter for SEK 50.8 million. The total remaining lease term is approximately 18 years and

There are no items matching the current filter
There are no more items matching the current filter
Back to top